E-therapeutics Share News (ETX)
ETX Share
ETX Share
ETX Share
ETX Share
ETX
ETX Share
ETX Level 2
ETX Live
ETX Broker
ETX Directors
ETX Financial
ETX
ETX Short
ETX
Last checked at -
Wed, 08th Jul 2020 16:21
e-Therapeutics PLC - Oxford-based drug discovery platform - Raises GBP750,000 in retail offer as part of GBP12.4 million fundraise announced on Tuesday.
Current stock price: 12.87 pence
Year-to-date change: up more than fivefold from 3.10p
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Invesco's Holding In e-Therapeutics Drops To Zero From 32%
Read moree-therapeutics Loss Narrows On Lower Costs, Collaboration Income
Read moree-therapeutics Loss Narrows On Lower Costs, New Collaboration Income
Read more(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is
Read moreLONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -
Read moreLONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery
Read moreWednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's
Read more
(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.
Read more(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).
Read moreLONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that
Read more(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.
Read moreLONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended
Read moreFriday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3
Read moreFriday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of
Read moreLONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,
Read more
Last checked at